Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 814
- Locations
- 10
- Primary Endpoint
- Measure the effectiveness of a multi-level telehealth-based intervention
Study Overview
Brief Summary
Through a multi-level remote intervention, the Vanderbilt-Ingram Cancer Center (VICC) seeks to improve comprehensive cancer care delivery to patients residing in rural communities with persistent poverty. We plan to do this by using telehealth to broaden the reach of our NCI-designated comprehensive cancer center in these communities
Detailed Description
Objectives:
- Evaluate the clinical effectiveness of a multi-level telehealth-based intervention for rural hospitals consisting of provider access to tumor board expertise that incorporates disease, patient and molecular tumor characteristics, together with patient access to a supportive care intervention to improve cancer care delivery.
- Evaluate the facilitators and barriers to future larger-scale dissemination and implementation of the multi-level intervention, designed to enhance quality rural cancer care delivery.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 21 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Provider and Patient:
- •At least 21 years of age or older and English speaking with the ability to provide informed consent
- •Oncology providers within designated VHAN oncology practices
- •Newly diagnosed or relapsed cancer patients of aforementioned oncology providers
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Measure the effectiveness of a multi-level telehealth-based intervention
Time Frame: Approximately 3 years
Estimate the facilitators to a future large-scale multi-level intervention
Time Frame: Approximately 3 years
Estimate the barriers to a future large-scale multi-level intervention
Time Frame: Approximately 3 years
Secondary Outcomes
No secondary outcomes reported
Investigators
Debra Friedman
Sponsor Investigator
Vanderbilt-Ingram Cancer Center